Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05924009 · ClinicalTrials.gov registry record · NA

Characterization of Gastric Evoked Potentials

A NA study of Healthy, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
155
Enrollment target
1
Study location

NCT05924009 is a NA study of Healthy that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 155 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05924009, a NA study of Healthy, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
155 participants
Enrollment target
1
Study location

Study Summary

This is an exploratory study that will determine and standardize how best to record gastric evoked potentials (GEPs) elicited by a non-invasive method of brain stimulation (Transcranial Magnetic Stimulation, TMS), by optimizing the TMS parameters and cortical sites necessary to evoke GEPs.

Conditions Studied

Interventions

  • PROCEDURE Transcranial Magnetic Stimulation, TMS

Study Locations (1)

Pennsylvania

  • University of Pittsburgh Medical Center - Pittsburgh

Trial Details

FieldValue
Enrollment Target 155 participants
Start Date 2023-06-17
Est. Completion 2026-12
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT05924009

The ClinicalTrials.gov registry entry for NCT05924009 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 155 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (76% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Magnetic Stimulation, TMS is the first listed.

NCT05924009 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05924009 about?

NCT05924009 is a clinical study titled "Characterization of Gastric Evoked Potentials". This is an exploratory study that will determine and standardize how best to record gastric evoked potentials (GEPs) elicited by a non-invasive method of brain stimulation (Transcranial Magnetic Stimulation, TMS), by optimizing the TMS parameters and cortical sites necessary to evoke GEPs.

What is the current status of trial NCT05924009?

This trial is currently recruiting. It is a NA study. The enrollment target is 155 participants. The study started on 2023-06-17. Estimated completion is 2026-12.

What conditions does trial NCT05924009 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT05924009?

The interventions under investigation include: Transcranial Magnetic Stimulation, TMS (PROCEDURE).

Who is sponsoring clinical trial NCT05924009?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05924009 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.